August 24, 2017 / 11:13 AM / in 4 months

BRIEF-Ionis Pharma urges shareholders to reject tender offer by TRC Capital

Aug 24 (Reuters) - Ionis Pharmaceuticals Inc

* Ionis recommends shareholders reject the below-the-market mini-tender offer by TRC Capital Corporation

* Received notice of unsolicited mini-tender offer by TRC Capital Corp of Ontario to purchase up to 2.5 million shares of co’ stock

* Recommends that stockholders do not tender their shares in response to TRC Capital’s offer​

* ‍TRC Capital corporation to purchase up to 2.5 million shares of Ionis’ common stock at a price of $44.88 per share in cash​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below